![]() BioNTech BioNTech is a biotechnology company developing immunotherapies for cancer and infectious diseases. | |||
Founding Date | Founding Date 1993 | Founding Date 2008 | Founding Date 2014 |
Type | Type Public | Type Public | Type Subsidiary |
Tags | |||
Locations | Locations Shenyang, CN HQ | Locations HQ | |
Employees | Employees 5,607 | Employees 6,133 | Employees 6 |
Financial | |||
Revenue (est.) | Revenue (est.) ¥7.8b (FY, 2023) | Revenue (est.) €3.8b (FY, 2023) | Revenue (est.) N/A |
Cost of goods | Cost of goods ¥839.4m (FY, 2023) | Cost of goods €416.4m (FY, 2023) | Cost of goods N/A |
Gross profit | Gross profit ¥7.1b (FY, 2023) | Gross profit €3.4b (FY, 2023) | Gross profit N/A |
Net income | Net income ¥1.6b (FY, 2023) | Net income €930.3m (FY, 2023) | Net income N/A |
BioNTech is a biotechnology company developing immunotherapies for cancer and infectious diseases.
View companyOrsenix is a clinical-stage biotech company focusing on oral therapies to treat cancer.
View company